Emergency Medicine
Infectious Disease
Public Health, Policy, and Training

Nejm News Une Mise à Jour The New England Journal of Medicine by Specialties


The New England Journal of Medicine: Search Results in Cardiology
The New England Journal of Medicine (NEJM) RSS feed -- Search Results in Cardiology. NEJM ( is a weekly general medical journal that publishes new medical research findings, review articles, and editorial opinion on a wide variety of topics of importance to biomedical science and clinical practice.

Angiotensin II for the Treatment of Vasodilatory Shock
31/12/69 - Shock is a life-threatening syndrome characterized by decreased organ perfusion that can progress to irreversible organ failure. Vasodilatory shock is the most common type of shock and is characterized by peripheral vasodilation and reduced blood pressure despite preserved cardiac output.…

Effect of Ularitide on Cardiovascular Mortality in Acute Heart Failure
31/12/69 - Acute presentation with new-onset heart failure and rapid worsening of preexisting heart failure are two of the most common causes of hospitalization worldwide. The disorder in each case is characterized by intravascular volume expansion and ventricular distention, which may cause myocardial injury…

Case 15-2017 ? A 27-Year-Old Woman with Anemia, Thrombocytosis, and Skin Lesions after Travel Abroad
31/12/69 - Presentation of Case. Dr. Alyssa R. Letourneau: A 27-year-old woman was evaluated in the infectious disease clinic of this hospital because of skin lesions, anemia, thrombocytosis, and an elevated blood alkaline phosphatase level. Eleven months before this presentation, the patient traveled abroad;…

Disease Modification in Acute Decompensated Heart Failure
31/12/69 - For patients with heart failure, hospitalization is associated with a downward clinical trajectory that accelerates with each subsequent admission. The risk of adverse events after hospitalization may be increased for patients who do not have reductions in levels of brain natriuretic peptide (BNP)…

Evacetrapib and Cardiovascular Outcomes in High-Risk Vascular Disease
31/12/69 - Pharmacologic reduction of the low-density lipoprotein (LDL) cholesterol level with statins substantially decreases the risks of death and complications from cardiovascular causes. Considerable interest has focused on the identification of approaches that might further reduce cardiovascular-event…

Instantaneous Wave-free Ratio versus Fractional Flow Reserve to Guide PCI
31/12/69 - Coronary revascularization is warranted only if a patient has one or more coronary-artery stenoses that are hemodynamically important. Large randomized studies have shown that fractional flow reserve (FFR) is superior to angiographic assessment for the detection of hemodynamically important…

Use of the Instantaneous Wave-free Ratio or Fractional Flow Reserve in PCI
31/12/69 - For the past 20 years, physiological measurements obtained during invasive procedures have been used to guide coronary revascularization. Pioneering work supported the use of flow measurements to make safe decisions about revascularization, but this approach was soon superseded by the use of…

Assessment of Stable Coronary Lesions
31/12/69 - In recent years, concerns have been raised about the appropriateness of performing percutaneous coronary intervention (PCI) in patients with stable coronary artery disease. One objective measure that is used to assess the potential benefit of revascularization is fractional flow reserve (FFR). FFR…

CABG at 50 (or 107?) ? The Complex Course of Therapeutic Innovation
31/12/69 - Anniversaries offer opportunities to commemorate crucial discoveries of modern medicine, such as vaccination (May 14, 1796), ether (October 16, 1846), and insulin (January 11, 1922). But zeroing in on specific dates can obscure important dynamics. Innovation in medicine is a complex and continuous…

Evolocumab and Clinical Outcomes in Patients with Cardiovascular Disease
31/12/69 - Low-density lipoprotein (LDL) cholesterol is a well-established and modifiable risk factor for cardiovascular disease. Monoclonal antibodies that inhibit proprotein convertase subtilisin?kexin type 9 (PCSK9) have emerged as a new class of drugs that effectively lower LDL cholesterol levels.…

Copyright © 2004/2011 Health.Cat

Annuaire de Sante | S'inscrire au MedSante  | Dictionnaire medicale  Forumed des médecins